The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Henney Christopher S since 2010.
This trader's CIK number is 1242880.
At the time of last reporting, Henney Christopher S was the Officer of Prothena Corp Public Ltd Co. (stock ticker symbol PRTA).
Also see all insider trading activities at Prothena Corp Public Ltd Co.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | CASC | 25,324 | $103,980 | 0 | $0 | 13,581 | $0 |
| 2014 | CASC | 0 | $0 | 0 | $0 | 19,352 | $0 |
| 2014 | CASC | 0 | $0 | 0 | $0 | 16,042 | $0 |
| 2012 | CASC | 0 | $0 | 0 | $0 | 3,377 | $0 |
| 2011 | CASC | 0 | $0 | 0 | $0 | 77,076 | $0 |
| 2010 | CASC | 0 | $0 | 0 | $0 | 3,166 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | PRTA | 0 | $0 | 47,000 | $2,573,167 | 47,000 | $568,622 |
| 2017 | PRTA | 0 | $0 | 15,900 | $964,898 | 15,900 | $105,734 |
| 2015 | PRTA | 0 | $0 | 20,000 | $1,282,060 | 20,000 | $130,600 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | ANTH | 200,000 | $149,800 | 0 | $0 | 0 | $0 |
| 2010 | ANTH | 0 | $0 | 0 | $0 | 40,887 | $42,399 |
1. Cascadian Therapeutics, Inc. (CASC)
2. Prothena Corp Public Ltd Co (PRTA)
3. Anthera Pharmaceuticals Inc (ANTH)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-24 | CASC | Option Ex | 2,375 | .00 | 0 |
| 2017-06-24 | CASC | Option Ex | 9,058 | .00 | 0 |
| 2017-06-12 | CASC | Option Ex | 2,148 | .00 | 0 |
| 2017-01-30 | CASC | Buy | 25,324 | 4.11 | 103,980 |
| 2014-06-13 | ONTY | Option Ex | 16,042 | .00 | 0 |
| 2014-03-11 | ONTY | Option Ex | 19,352 | .00 | 0 |
| 2012-05-03 | ONTY | Option Ex | 989 | .00 | 0 |
| 2011-12-31 | ONTY | Option Ex | 2,388 | .00 | 0 |
| 2011-12-01 | ONTY | Option Ex | 25,000 | .00 | 0 |
| 2011-10-10 | ONTY | Option Ex | 50,000 | .00 | 0 |
| 2011-06-12 | ONTY | Option Ex | 2,076 | .00 | 0 |
| 2010-12-14 | ONTY | Option Ex | 3,166 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-07-14 | PRTA | Option Ex | 11,108 | 11.33 | 125,853 |
| 2021-07-14 | PRTA | Sale | 11,108 | 55.72 | 618,937 |
| 2021-07-12 | PRTA | Sale | 23,892 | 57.61 | 1,376,442 |
| 2021-07-12 | PRTA | Option Ex | 23,892 | 10.28 | 245,609 |
| 2021-06-25 | PRTA | Option Ex | 12,000 | 16.43 | 197,160 |
| 2021-06-25 | PRTA | Sale | 12,000 | 48.15 | 577,788 |
| 2017-09-28 | PRTA | Option Ex | 900 | 6.65 | 5,985 |
| 2017-09-28 | PRTA | Sale | 900 | 70.00 | 63,000 |
| 2017-07-17 | PRTA | Sale | 5,000 | 66.13 | 330,670 |
| 2017-07-17 | PRTA | Option Ex | 5,000 | 6.65 | 33,250 |
| 2017-02-27 | PRTA | Option Ex | 5,989 | 6.65 | 39,826 |
| 2017-02-27 | PRTA | Sale | 5,989 | 57.16 | 342,349 |
| 2017-02-17 | PRTA | Option Ex | 4,011 | 6.65 | 26,673 |
| 2017-02-17 | PRTA | Sale | 4,011 | 57.06 | 228,879 |
| 2015-11-27 | PRTA | Option Ex | 5,000 | 6.65 | 33,250 |
| 2015-11-27 | PRTA | Sale | 5,000 | 75.00 | 375,000 |
| 2015-10-29 | PRTA | Option Ex | 5,000 | 6.65 | 33,250 |
| 2015-10-29 | PRTA | Sale | 5,000 | 55.00 | 275,000 |
| 2015-08-07 | PRTA | Sale | 10,000 | 63.21 | 632,060 |
| 2015-08-07 | PRTA | Option Ex | 10,000 | 6.41 | 64,100 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-06-29 | ANTH | Buy | 200,000 | .75 | 149,800 |
| 2010-04-01 | ANTH | Option Ex | 40,887 | 1.04 | 42,399 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Henney Christopher S (Officer of Prothena Corp Public Ltd Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.